This webinar, hosted by Sano CEO Dr. Patrick Short and featuring David Ochoa, Platform Coordinator at Open Targets, explores the significance of human genetics ...
Continue reading
As precision medicine trials increasingly depend on genetic eligibility criteria, the process of testing, interpreting results, and guiding patients through the...
Continue reading
Genetic testing has become a defining capability in biotechnology and pharmaceutical development. By revealing the specific genetic variants that influence dise...
Continue reading
While lifestyle choices and environment can impact risk, genes are often what most affect how likely a person is to develop a disease. People commonly have diff...
Continue reading
CRISPR (clustered regularly interspaced short palindromic repeats) and CRISPR-associated (Cas) proteins were first characterized as part of bacterial immune def...
Continue reading
Pharmacogenomics, also known as pharmacogenetics, is a field of research dedicated to investigating how an individual's genetic makeup influences their response...
Continue reading
In this blog, we're exploring whether ALS can be caught early, including the tests that may be used in order to diagnose ALS, and if there are any measures that...
Continue reading
The success of any precision medicine program depends on the quality of the target it pursues. A well-validated genetic target shapes everything downstream: whi...
Continue reading
When an individual undergoes genetic testing, they often expect to find definitive answers about their genes. However, around 20% of genetic tests identify vari...
Continue reading
Genetic data is now central to how drugs are discovered, developed, and brought to patients. For teams designing precision medicine programs, understanding wher...
Continue reading